PHIA Koninklijke Philips N.V.

Philips announces collaboration with American Telemedicine Association to further commitment to telehealth

Philips announces collaboration with American Telemedicine Association to further commitment to telehealth

June 18, 2020

  • Two leading organizations join forces to drive future telehealth strategies across hospital settings into the home propelled by COVID-19
  • Jeroen Tas, Chief Strategy & Innovation Officer at Philips to deliver executive spotlight address at Annual ATA Virtual Conference

Amsterdam, the Netherlands and Washington, DC – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has once again joined forces with the American Telemedicine Association () to help further the adoption of telehealth across the industry, demonstrating its commitment to connecting care across acute, post-acute and home care settings. The continued collaboration spotlights the growing adoption and momentum in telehealth amidst COVID-19, and the need to convey the exponential shift to telehealth capabilities.

The COVID-19 pandemic has increased the share of Americans participating in telehealth from 11% in 2019 to 46% today, with healthcare systems reporting a 50 to 175-fold increase in telehealth volume compared to pre-pandemic levels [1]. As the world begins to move from the first wave of reactive care, into a more proactive phase and beyond, virtual care solutions are supporting the recovery of COVID patients as they transition through their care journey, and non-COVID patients as they return to elective surgeries, diagnoses, prevention and treatments that have been put on hold since the onset of the pandemic.  

“There is no better time for Philips to team with the ATA. Philips is creating proactive, AI-powered solutions to improve patient monitoring, precision diagnosis and clinical workflows at every point along the continuum. This directly aligns with our vision for telehealth -- to drive the transformation of health by integrating virtual care from the hospital to physician offices and the home,” said Ann Mond Johnson, CEO, the ATA. “Major industry players like Philips joining the ATA reconfirms the importance of telehealth and creates important new opportunities to deliver quality care whenever and wherever it’s needed.”

“Philips has been a leader in telehealth across acute care and post-acute care settings in the hospital and in the home for over three decades, helping health systems deploy and scale telehealth solutions to help improve patient outcomes, enhance patient and staff experience and lower care costs,” said , Chief Business Leader Connected Care, member of the Executive Committee at Royal Philips. “Our alignment with ATA will help promote strong  growth and faster adoption of telehealth and policy changes escalated during the COVID crisis as we pivot to innovate ‘virtual first’ strategies to support hospitals, payers, and patients across care settings, including digital health technologies to support healthy living in the home.”

Expanding virtual connected care through partnership and innovation

COVID-19 has propelled digital technology to the forefront as healthcare systems rapidly expand telehealth, including virtual care, remote patient monitoring, data analytics and medical record-sharing capabilities to care for patients with COVID-19. In response to the pandemic, Philips has been working with customers around the world to rapidly develop and deploy scalable telehealth solutions to support frontline care professionals and their patients. Philips recently received 510(k) clearance from the Food and Drug Administration for its (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital.  The wearable biosensor enhances clinical surveillance as part of the Philips patient deterioration detection solution to help clinicians detect risk so they can intervene earlier and help improve care for patients in lower acuity care areas. 

The Philips Virtual Connected Care Ecosystem comprises people, processes, and technology. At the core of the platform are three Philips FDA-cleared, vendor agnostic solutions currently utilized to provide remote critical care to patients in the hospital and at home including:

  • FDA-cleared Tele-ICU software (eCare Manager) with AI-enabled decision support algorithms to enable critical care clinicians to work virtually coordinating with on-site clinical staff to provide care to COVID-19 patients from the hospital into the home;  
  • Cloud-based software platform (IntelliSpace Corsium) provides real-time patient monitoring tracking during patient transport;
  • Patient centered apps (eCare Coordinator for providers/eCare Companion for patients) deployed in a home environment using mobile IOT (Internet of Things) monitoring devices to allow healthcare providers to monitor physiologic survey data and communicate directly with the patients they are providing care to as needed.

Telehealth expanding access to care for millions of U.S. veterans

Philips has partnered with The U.S. Department of Veterans Affairs (VA), The American Legion and Veterans of Foreign Wars (VFW) on Advancing Telehealth through Local Access Stations known as the ATLAS Program, bringing care to Veterans where and when they need it most.  Launching in Eureka, Montana, followed by Springfield, Virginia, Atlas kicked off in 2019 with 10 pilot sites to be installed before the end of 2020. Philips has also taken the current  configuration being used for the ATLAS Program to now create the commercial Philips Virtual Care Station that will further expand access to care through non-traditional locations such as retail health, community and university environments.

ATA 2020 Annual Virtual Conference and Expo

The 2020 will take place virtually, beginning June 22 – 26, 2020. Participants will have access to keynote discussions and panel sessions ranging in topics from interoperability and cybersecurity, to remote patient monitoring and disparity within telehealth offerings.  On June 24, at 11:00AM – 11:20AM ET, , Chief Innovation & Strategy Officer at Royal Philips how Philips responded to the COVID-19 pandemic and worked with customers around the world in developing telehealth  solutions to support front-line care professionals. He will also share his vision on how healthcare leaders should embrace new ways of thinking to make possible digital, more modular and scalable, telehealth solutions.

[1] McKinsey

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail :

Twitter:

Gina Cella

American Telemedicine Association

Tel:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

About the ATA

As the only organization completely focused on advancing telehealth, the  is committed to ensuring that everyone has access to safe, affordable, and appropriate care when and where they need it, enabling the system to do more good for more people. ATA represents a broad and inclusive member network of technology solution providers and payers, as well as partner organizations and alliances, working to advance industry adoption of telehealth, promote responsible policy, advocate for government and market normalization, and provide education and resources to help integrate virtual care into emerging value-based delivery models. @americantelemed #gotelehealth #ATApolicy



 

Attachments

EN
18/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips launches RADIQAL study to generate real-world evidence for new...

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the USPrimary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the (R...

 PRESS RELEASE

Philips launches real-time 3D intracardiac imaging in Europe, expandin...

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real timeCatheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – (NYSE: PHG...

 PRESS RELEASE

Philips successfully prices offering of Notes for EUR 1 billion to be ...

Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects May 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes due 2035 (the “Notes”) under its European Medium Term Note (EMTN) program. The net proceeds will be used for general corporate purposes, the repayment of 2026 debt maturities, and to refinance or finance any ...

 PRESS RELEASE

Philips Future Health Index 2025: AI poised to transform global health...

Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, , highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. H...

Koninklijke Philips N.V.: 1 director

A director at Koninklijke Philips N.V. bought 8,176 shares at 24.410USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch